CALGARY, ALBERTA--(Marketwire - Oct. 20, 2008) - Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) announces today Dr. Alan Moore, President and CEO, will be participating in a panel discussion at BioFlorida's 11th Annual Conference to be held October 19-21 at the Ritz-Carlton in Amelia Island, Florida. The panel discussion, titled "Individualized Medicine", will be chaired by Dr. Todd E. Golde, Professor and Consultant in the Department of Neuroscience at the Mayo Clinic Jacksonville. In addition to Dr. Moore, the panel includes Dr. Daniel Kelly, Scientific Director and Professor at the Burnham Institute for Medical Research and Dr. Dennis Steindler, Professor of Neuroscience and Neurosurgery at the University of Florida, College of Medicine.
